Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tepilta for Radiation-induced Oesophagitis
NCT01336530Phase 3Terminated
- Sponsor
- Meda
- Start
- Apr 2011
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of Tepilta in radiation-induced esophagitis, sponsored by Meda. Started Apr 2011; status: terminated.
02
Drugs
Tepilta
03
Conditions
radiation-induced esophagitis
Beyond the preview
Go deeper on NCT01336530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01336530.